Regulators finalize a CMS rule that changes Medicare payments starting in 2027, including major reductions for drugs covered under the 340B program and expanded “site-neutral” payment policies between different provider settings. The rule is finalized as part of the agency’s annual outpatient hospital payment updates.
Across outlets, coverage focuses on how the changes affect hospitals and providers. BioPharma Dive and Healthcare Dive emphasize that the rule would “slash” 340B payments and “equalize” or align some payments across care sites, describing strong opposition from hospitals. Fierce Healthcare adds a different context: while the final outpatient pay update includes modifications to the overall payment picture, it provides “little relief” on 340B, and it frames the final rate increase as smaller than initially proposed. Taken together, the reporting centers on both the specific 340B and site-neutral policy shifts and the limited extent to which hospitals receive compensating increases elsewhere in the outpatient payment rule.
